GLP-1 Price Guide Compare prices
Legal disclosure · Updated June 1, 2026

Affiliate Disclosure

Current affiliate relationships, what would change with future relationships, and what wouldn't.

Updated June 1, 2026Current: none

Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026

Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
Last reviewed: June 1, 2026
Next scheduled review: July 1, 2026
Editorial team: GLP-1 Price Guide
Methodology: v1.0 pricing framework

Affiliate Disclosure

GLP-1 Price Guide is an editorial pricing publication. Provider rankings are based on publicly available pricing, transparency, provider oversight, pharmacy sourcing, and patient affordability factors — not paid placements. If a material relationship exists with any provider mentioned, it is disclosed on the relevant page and on this disclosure page.

Current Affiliate Relationships

As of June 1, 2026: None disclosed.

This means GLP-1 Price Guide does not currently have affiliate, sponsorship, or material partnership arrangements with any compounded GLP-1 telehealth provider, compounding pharmacy, or related commercial entity that would influence editorial coverage or rankings.

What "Material Relationship" Means

A material relationship includes:

If Affiliate Relationships Are Established Later

Should GLP-1 Price Guide establish affiliate, sponsorship, or material relationships with any provider in the future:

  1. This disclosure page will be updated within 7 days of the relationship being established
  2. The specific relationship will be disclosed on every relevant page (homepage, provider review, ranking pages)
  3. The relationship will be noted with appropriate link attributes (e.g., rel="sponsored")
  4. Editorial methodology will remain unchanged — rankings will continue to be based on the v1.0 pricing methodology, not on affiliate revenue

What Affiliate Relationships Would NOT Change

Even with affiliate relationships in the future, these editorial principles remain non-negotiable:

Outbound Links

GLP-1 Price Guide links to provider websites, FDA pages, medical journals, and regulatory sources for reader convenience. Outbound links to commercial providers use rel="nofollow noopener" attributes. If/when affiliate relationships are established, those specific links will use rel="sponsored" attributes per FTC and search engine guidelines.

Reader Trust

The reason GLP-1 Price Guide exists is to provide pricing transparency that competing rankings (often sponsored or affiliate-driven) do not. We believe editorial integrity is the foundation of reader trust. Any affiliate relationship that would compromise this integrity is not worth establishing.

Questions

Questions about this disclosure or specific provider relationships: glponepriceguide@gmail.com

FTC Compliance

This disclosure complies with the Federal Trade Commission's Endorsement Guides (16 CFR Part 255), which require clear and conspicuous disclosure of material connections between endorsers and advertisers.

Important medical and regulatory disclosure Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.